Who owns Novozymes A/s Unspons Adr adr?
- Ticker: NVZMY
- CUSIP Number: 670108109
Tip: Access positions for across all investors
Analyze quarterly positions in Novozymes A/s Unspons with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Novozymes A/s Unspons stock
Who bought or sold Novozymes A/s Unspons Adr adr this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Rhumbline Advisers | 10k | $626k | -3% | Sep 2025 |
|
| Sterling Capital Management | 6.4k | $394k | -2% | Sep 2025 |
|
| Boston Common Asset Management | 4.6k | $283k | 51% | Sep 2025 |
|
| S & Co | 4.5k | $275k | 0% | Sep 2025 |
|
| GAMMA Investing | 2.4k | $147k | 2% | Sep 2025 |
|
| Pnc Financial Services | 1.6k | $96k | -3% | Sep 2025 |
|
| FTB Advisors | 249.00 | $18k | 100% | Jun 2025 |
|
| Salomon & Ludwin | 186.00 | $11k | 3620% | Sep 2025 |
|
| Copeland Capital Management | 49.00 | $3.0k | 0% | Sep 2025 |
|
| Ameriflex Group | 28.00 | $1.7k | 100% | Sep 2025 |
|
Who sold out of Novozymes A/s Unspons?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Mar Vista Investment Partners | Jun 2025 | 702.00 | $50k |
| Skopos Labs | Jun 2025 | 81.00 | $5.8k |